
Results
9
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
9 companies
Anheuser-Busch InBev
Market Cap: €141.0b
Produces and sells beer in North America, Middle Americas, South America, Europe, the Middle East, Africa, and the Asia Pacific.
ABI
€72.28
7D
3.8%
1Y
17.6%
UCB
Market Cap: €46.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€244.60
7D
6.4%
1Y
55.4%
argenx
Market Cap: €43.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€705.80
7D
4.5%
1Y
35.6%
ageas
Market Cap: €13.1b
Engages in insurance business.
AGS
€68.65
7D
0.7%
1Y
19.2%
Fagron
Market Cap: €1.9b
A pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide.
FAGR
€25.25
7D
5.0%
1Y
18.0%
Etex
Market Cap: €1.0b
Manufactures and sells building materials in the United Kingdom, France, other European countries, Poland, Italy, Spain, Germany, Benelux, Latin America, Australia, Africa, Asia, and internationally.
094124453
€13.10
7D
0.8%
1Y
-1.5%
Sipef
Market Cap: €996.5m
Operates as an agro-industrial company.
SIP
€95.60
7D
-4.4%
1Y
52.7%
Miko
Market Cap: €75.8m
Engages in the coffee roasting business under the Miko brand name in Belgium, France, the Netherlands, the United Kingdom, Germany, Denmark, Norway, Sweden, Poland, the Czech Republic, Slovakia, and Australia.
MIKO
€61.00
7D
0%
1Y
15.1%
European Medical Solutions
Market Cap: €20.2m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally.
ALEMS
€4.78
7D
-2.4%
1Y
13.8%